SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227749
Filing Date
2023-09-01
Accepted
2023-09-01 17:29:29
Documents
12
Period of Report
2023-08-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d549067d8k.htm   iXBRL 8-K 26156
  Complete submission text file 0001193125-23-227749.txt   144816

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fate-20230830.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20230830_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20230830_pre.xml EX-101.PRE 10829
6 EXTRACTED XBRL INSTANCE DOCUMENT d549067d8k_htm.xml XML 3273
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 231233495
SIC: 2836 Biological Products, (No Diagnostic Substances)